X
Email:
sales@ruixibiotech.com

90Y-ibritumomab tiuxetan

90Y-ibritumomab tiuxetan

Catalog # Pkg Size Price(USD) Quantity Buy this product
R-M2-9193 1EA inquiry

Product description

The target site of 90Y-ibritumomab tiuxetan is CD20, which can be used for the treatment of refractory non Hodgkin lymphoma.

Virtual price, please inquire if needed.

We can mass produce (kg level), process scaling up, pilot supply, raw material supply, and intermediate production. Our production technology is mature and more cost-effective. Feel free to inquire at any time.


Appearance N/A
Molecular weight N/A
Purity >90%
Solubility N/A
Molecular formula N/A
Storage -20℃, protected from light and moisture
Transportation 4-25℃ temperature for up to 3 weeks
Stability 1 year
Document

Related Product